| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.009 | 1 |